RN7SL745P

Across TCGA pan-cancer cohorts, RN7SL745P RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated RN7SL745P data layer.

The strongest signal is observed in testicular germ cell tumors (TGCT), where higher RN7SL745P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RN7SL745P expression acts as an unfavorable survival marker, although some lineages such as HNSC and CHOL show a favorable association.

TGCT, READ, and LIHC are the cancer types where RN7SL745P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
TGCT	DFS	Tertile	II,III,IV	0.015	0.919	<.001	36	view →
READ	DFS	Tertile	III,IV	0.082	0.749	<.001	18	view →
LIHC	OS	Tertile	All	0.637	0.792	.004	18	view →
THCA	DFS	Tertile	IV	0.349	0.907	<.001	18	view →
HNSC	DFS	Quartile	II,III,IV	0.806	0.666	.005	17	view →
LGG	DFS	Tertile	All	0.622	0.759	.007	15	view →
GBM	DFS	Quartile	All	0.121	0.249	<.001	12	view →
PAAD	DFS	Quartile	All	0.143	0.314	.008	10	view →
CHOL	DFS	Quartile	All	1.000	0.229	.008	9	view →
PCPG	OS	Tertile	All	0.944	1.000	.045	9	view →
STAD	OS	Tertile	IV	0.557	0.116	.017	6	view →
BLCA	DFS	Tertile	All	0.690	0.580	.032	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

RN7SL745P–TGCT (DFS)

Open the TGCT breakdown →